CINCINNATI, Ohio, March 17 -- The Department of Energy's Office of Environmental Management issued the following news release on March 16, 2022: The U.S. Department of Energy's Office of Environmental Management (EM) issued a Final Request for Proposal (RFP) for the Technical Assistance Contract for EM Field Sites (Site TACs) multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract and for the EM- Los Alamos Field Office (EM-LA) TAC Support Task Order. The purpose of this acquisi  more

DURHAM, North Carolina, March 16 (TNSRes) -- Duke Health issued the following news release: Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report. Publishing online March 15 in the journal Cell Reports, the research team describes an important advancement in what is a complex vaccine development process. The approach uses mRNAs within lipid nanoparticles tha  more

WASHINGTON, March 15 -- The Defense Nuclear Facilities Safety Board's Resident Inspector in Los Alamos National Laboratory issued the following weekly report: MEMORANDUM FOR: Christopher J. Roscetti, Technical Director FROM: D. Gutowski and J. Plaue, Resident Inspectors SUBJECT: Los Alamos Activity Report for Week Ending February 25, 2022 Chemistry and Metallurgy Research Building: Subcontractor personnel recently commenced more invasive decontamination and decommissioning activities such as  more

WASHINGTON, March 18 -- Sen. John Barrasso, R-Wyoming, ranking member of the Senate Energy and Natural Resources Committee, issued the following news on March 17, 2022: U.S. Senator John Barrasso (R-WY), ranking member of the Senate Committee on Energy and Natural Resources (ENR), delivered the following remarks at a nominations hearing. The hearing featured testimony from Dr. Kathryn Huff, nominee to be assistant secretary for Nuclear Energy at the Department of Energy. For more informatio  more

SCOTTSDALE, Arizona, March 19 (TNSRes) -- The Translational Genomics Research Institute issued the following news release: * * * Named for a respected Arizona scientist, this trial uses a combination of drugs against advanced cancer in patients where other treatments have failed * * * The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, in association with HonorHealth Research and Innovation Institute and Systems Biology Ireland (SBI), have begun a clinical tri  more